132 related articles for article (PubMed ID: 2435630)
1. Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease.
Cella G; Scattolo N; Vio C; Stevanato F; Lavagnini T; Padovan D; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):646-54. PubMed ID: 2435630
[TBL] [Abstract][Full Text] [Related]
2. Platelet factor 4 release induced by intravenous administration of heparin.
Cella G; Scattolo N; Cappellato MG; Girolami A; Strauss WE; Sasahara AA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):165-74. PubMed ID: 2581862
[TBL] [Abstract][Full Text] [Related]
3. Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis.
O'Brien JR; Etherington MD; Pashley M
Thromb Haemost; 1984 Jul; 51(3):354-7. PubMed ID: 6495255
[TBL] [Abstract][Full Text] [Related]
4. Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders.
Cella G; Colby SI; Taylor AD; McCracken L; Parisi AF; Sasahara AA
Thromb Res; 1983 Mar; 29(5):499-509. PubMed ID: 6222505
[TBL] [Abstract][Full Text] [Related]
5. Short-term effect of exercise on platelet factor 4 in normal subjects and in patients with coronary artery disease.
Placanica G; Migliau G; Nasso G; Rosso R; Tallarico D; Migliau G
Cardiologia; 1999 Nov; 44(11):993-6. PubMed ID: 10686775
[TBL] [Abstract][Full Text] [Related]
6. Platelet-released proteins as molecular markers for the activation process.
Walz DA
Semin Thromb Hemost; 1984 Oct; 10(4):270-9. PubMed ID: 6240116
[TBL] [Abstract][Full Text] [Related]
7. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
Artery; 1980; 8(1):73-9. PubMed ID: 6158934
[TBL] [Abstract][Full Text] [Related]
8. Lack of increase or reduction in circulating platelet factor 4 and heparin-releasable platelet factor 4 in symptomatic patients with asthma.
Luzzatto G; Cella G; Boschetto P; Fabbri L
J Lipid Mediat; 1993 Jun; 7(2):151-4. PubMed ID: 8400116
[TBL] [Abstract][Full Text] [Related]
9. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
[TBL] [Abstract][Full Text] [Related]
10. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia.
Atalar E; Haznedaroglu IC; Acil T; Ozer N; Kilic H; Ovunc K; Aksoyek S; Nazli N; Kes S; Kabakçi G; Kirazli S; Ozmen F
Platelets; 2003; 14(7-8):407-11. PubMed ID: 14713509
[TBL] [Abstract][Full Text] [Related]
11. Increased releasability of platelet products and reduced heparin-induced platelet factor 4 release from endothelial cells in bronchial asthma.
Yasuba H; Chihara J; Kino T; Satake N; Oshima S
J Lipid Mediat; 1991; 4(1):5-21. PubMed ID: 1832572
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of thrombotic risk in type 2 diabetes: determination of platelet factor 4 and beta thromboglobulin].
Diop S; Ka-Cisse M; Toure-Fall AO; Diagne Fall-Sarr F; Diop SN; Thiam D; Diakhate L
Dakar Med; 2002; 47(2):247-51. PubMed ID: 15776686
[TBL] [Abstract][Full Text] [Related]
13. High heparin released platelet factor 4 in uncomplicated type 1 diabetes mellitus.
Cortellaro M; Cofrancesco E; Vicari A; Boschetti C; Della Volpe A; Moreo G; Pozza G; Polli EE
Thromb Res; 1990 Jun; 58(6):571-6. PubMed ID: 2143603
[TBL] [Abstract][Full Text] [Related]
14. Beta thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis.
Kowal-Bielecka O; Kowal K; Lewszuk A; Bodzenta-Lukaszyk A; Walecki J; Sierakowski S
Ann Rheum Dis; 2005 Mar; 64(3):484-6. PubMed ID: 15708900
[TBL] [Abstract][Full Text] [Related]
15. PF,VIII/vWF,B-TG and PF4 in diabetic subjects, both type 1 and 2, with and without retinopathy.
Guastamacchia E; Di Paolo S; Santoro G; Damato A; Nardelli GM; Giorgino R
Boll Soc Ital Biol Sper; 1985 Apr; 61(4):499-505. PubMed ID: 2412573
[No Abstract] [Full Text] [Related]
16. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG].
Ferri GM; Afeltra A; Caccavo D; Amoroso A
Recenti Prog Med; 1986 Jan; 77(1):31-2. PubMed ID: 2422709
[No Abstract] [Full Text] [Related]
18. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
[TBL] [Abstract][Full Text] [Related]
19. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation.
Cofrancesco E; Colombi M; Cristoforetti G; Pogliani EM
Thromb Haemost; 1984 Feb; 51(1):105-7. PubMed ID: 6202020
[TBL] [Abstract][Full Text] [Related]
20. Platelet alpha granule release in diabetes mellitus.
Sacchi S; Curci G; Piccinini L; Cucci F; Messerotti A; Roncaia R; Benedetti PG
Scand J Clin Lab Invest; 1985 Apr; 45(2):165-8. PubMed ID: 2408317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
